Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

GMED 24.75 0.00 (0.00%)
price chart
Company Shares of Globus Medical, Inc. (NYSE:GMED) Drops by -3.43%
Globus Medical, Inc. (NYSE:GMED) has lost 3.43% during the past week and dropped 11.8% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 4.31%.
Brokerage Perspectives on Globus Medical, Inc. (NYSE:GMED)  Markets Daily
Globus Medical PT Lowered to $26.00 (GMED)  Financial Wisdom Works
Globus Medical, Inc. Short Interest Update
Globus Medical, Inc. (NYSE:GMED), A rise of 200,346 shares or 2.7% was seen in the short interest of Globus Medical, Inc.. Even as the interest increased from 7,417,632 shares on July 31,2015 to 7,617,978 shares on August 14,2015, the days to cover ...
Value Stock to Watch: Globus Medical, Inc. (NYSE:GMED)  Enterprise Leader
Zacks Short Term Rating on Globus Medical, Inc. (NYSE:GMED)  OTC Outlook
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Globus Medical Announces the Acquisition of Branch Medical Group, Inc.
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire Branch Medical Group, Inc. (“BMG”), a third party manufacturer of ...
Two Montco companies agree to $52.9M deal  Philadelphia Business Journal (blog)
Globus Medical to pay $53m for key supplier Branch Medical  Mass Device
Globus Medical, Inc. (NYSE:GMED) Price Target Update
Globus Medical, Inc. (NYSE:GMED) stock has received a short term price target of $ 31 from 7 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.94.
Globus Medical, Inc. Engages Grant Thornton LLP as Independent Auditor
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that the Audit Committee of its Board of Directors has engaged Grant Thornton LLP as its independent registered ...
Globus Medical, Inc. Price Target Update
Globus Medical, Inc. (NYSE:GMED) should head towards $31 per share according to 7 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $25 per share.
Leerink Swann Rating Update on Globus Medical, Inc. (NYSE:GMED)
In the statement by the brokerage house, Leerink Swann maintains its outlook on Globus Medical, Inc. (NYSE:GMED). The current rating of the shares is Outperform , according to the research report released by the firm.
Globus Medical Price Target Raised to $32.00 (GMED)  The Legacy
Globus Medical Lifted to "Buy" at Zacks (GMED)  Mideast Time
Cervical Total Disc Replacement Market - Global Industry Analysis to 2020, by ...
... total disc replacement market are Johnson & Johnson, Applied Spine Technologies, Inc., Abbott Laboratories, Zimmer, Inc., Synthes AG, Medtronic, Inc., Innovative Spinal Technologies, Inc., Dynamic Spine, Inc., Globus Medical, Inc., and Stryker ...
Globus Medical, Inc. (NYSE:GMED) Analyst Price Target Update
Globus Medical, Inc. (NYSE:GMED): The stock price is expected to reach $ 29 in the short term. The number of analysts agreeing with this consensus is 8. The higher estimate for the short term price target is at $33 while the lower estimate is at $24.
Large Outflow of Money Witnessed in Globus Medical, Inc.  Money Flow Index
Analyst Watch: Globus Medical, Inc. (NYSE:GMED)  Markets Daily